ICON
A Principal Study Start Up Associate at ICON coordinates operational and strategic aspects of clinical trial submissions for countries in scope of the EU Clinical Trials Regulation. The role focuses on developing and driving EU CTR submission strategies, managing timelines and milestones, and ensuring timely, compliant submissions into the EMA CTIS in collaboration with central and country teams.
Headquarters
Austin, Texas, United States
Company Size
201-500 employees
Founded
2017
ICON develops advanced construction technologies—large‑scale 3D printing robotics, proprietary software, and engineered materials—to accelerate and democratize building. The company supplies hardware, software and integrated construction services for homes and infrastructure, partnering with developers, governments and humanitarian organizations to deliver faster, lower‑cost, resilient structures. By automating construction and optimizing materials, ICON reduces labor, waste and build time while enabling new designs and scalable community solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for ICON.
ICON didn’t post a salary, so this is our estimate from similar listings.
ICON launches Titan printer rollout for construction companies
2 days ago
Study Start Up Associate I
ICON plc
Regulatory & Start-Up Specialist 2, IQVIA Biotech, Nordic Regions
IQVIA
Regulatory Submission Professional - Clinical Trial Submissions in EU
Novo Nordisk A/S
Regulatory Submission Professional - Clinical Trial Submissions in EU
Novo Nordisk A/S
Study Start-Up Lead
Fortrea
Study Start-up Lead
Clinilabs